Geoff MacKay

Geoff Mackay

President & Chief Executive Officer
AVROBIO, USA & CANADA

Geoff is an experienced CEO with proven success leading innovative businesses. While CEO of Organogenesis Inc., the company treated 1 million patients with living cell therapies, received the first FDA CBER allogeneic cell-therapy approval and achieved an unparalled position within regenerative medicine. Geoff is also Managing Director of eGenesis, applying CRISPR Cas-9 gene editing to xenotransplantation. Geoff spent 11 years at Novartis in senior leadership positions within the Global Transplantation & Immunology franchise. Past activities include Chairman of the Board of MassBio, Chairman of the Board of the Alliance of Regenerative Medicine, and Advisory Council to the Health Policy Commission for Massachusetts. Through his public and private enterprise work, Geoff is dedicated to applying innovation to reshape and improve the quality of healthcare.

Return to Board of Directors

 

Subscribe to our mailing list to receive CCRM’s monthly newsletter.

 
 

You have Successfully Subscribed!